Abstract
The blood–brain barrier transport characteristics of racemic baclofen and the separate R- and S-enantiomers have been determined in vivo in rats by using the unit impulse response methodology. Transport rate was determined as blood–brain barrier clearance, the volume of plasma per unit time cleared of baclofen by transport across the blood–brain barrier. Plasma elimination kinetics and CSF elimination kinetics did not differ among racemic baclofen and the R-and S-enantiomers. Transport of each compound could be described by a linear V(t] curve, suggesting the absence of saturable transport processes in the concentration range studied. However, for R-baclofen the blood–brain barrier clearance (4.7 ± 1.0 µl/min, mean ± SE; n = 6) and cumulative transported amount (0.085 ± 0.007%; n = 6) were significantly higher than these values for the S-enantiomer (1.1 ± 0.3 µl/min, 0.031 ± 0.005%; n = 6) and racemic baclofen (1.0 ± 0.1 µl/min, 0.036 ± 0.003%; n = 6). These findings indicate that there is stereoselective transport of baclofen across the blood–brain barrier.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
H. U. Fehr and H. J. Bein. Sites of action of a new muscle relaxant (baclofen, Lioresal, Ciba 34 647-Ba). J. Int. Med. Res. 2:36–47 (1974).
J. W. Faigle, H. Keberle, and P. H. Degen. Chemistry and pharmacokinetics of baclofen. In R. G. Feldman, R. R. Young, and W. P. Koella (eds.), Spasticity: Disordered Motor Control, Year Book Medical, Chicago, 1980, pp. 461–475.
W. H. Oldendorf. Brain uptake of radiolabeled amino acids amines and hexoses after arterial injection. Am J Physiol. 221:1629–1639 (1971).
K. L. Audus and R. T. Borchardt. Characteristics of the large neutral amino acid transport system of bovine brain microvessel endothelial cell monolayers. J. Neurochem. 47:484–488 (1986).
J. B. M. M. Van Bree, K. L. Audus, and R. T. Borchardt. Carrier-mediated transport of baclofen across monolayers of bovine brain endothelial cells in primary culture. Pharm. Res. 5:369–371 (1988).
J. B. M. M. Van Bree, A. V. Baljet, A. Van Geyt, A. G. De Boer, M. Danhof, and D. D. Breimer. The unit impulse response procedure for the pharmacokinetic evaluation of drug entry into the central nervous system. J. Pharmacokin. Biopharm. 17:441–462 (1989).
E. W. Wuis, M. J. M. Dirks, E. F. S. Termond, T. B. Vree, and E. Van der Kleijn. Comparison of the pharmacokinetics of intravenously administered rac-baclofen and its (−)-(R)-and (+)-(S)-enantiomers in dogs. Int. J. Clin. Pharmacol. Res. 10:239–246 (1989).
H. Spahn, D. Krauss, and E. Mutschler. Enantiospecific high-performance liquid chromatographic determination of baclofen and its fluoro analogue in biological material. Pharm. Res. 5:107–112 (1988).
F. Joo. Current aspects of the development of the blood-brain barrier. Int. J. Dev. Neurosci. 5:369–372 (1987).
P. Veng-Pedersen. Linear and nonlinear system approaches in pharmacokinetics. I. J. Pharmacokin. Biopharm. 16:413–472 (1988).
G. J. Mammen (ed.). Clinical Pharmacokinetics Drug Data Handbook 1989, ADIS, Auckland, 1989, p. 37.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
van Bree, J.B.M.M., Heijligers-Feijen, C.D., de Boer, A.G. et al. Stereoselective Transport of Baclofen Across the Blood–Brain Barrier in Rats as Determined by the Unit Impulse Response Methodology. Pharm Res 8, 259–262 (1991). https://doi.org/10.1023/A:1015812725011
Issue Date:
DOI: https://doi.org/10.1023/A:1015812725011